Drugs from discovery to approval

The new edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manuf...

Full description

Saved in:
Bibliographic Details
Main Author: Ng, Rick (Author)
Format: Book
Language:English
Published: Hoboken, New Jersey John Wiley & Sons, Hoboken 2004
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000#i 4501
001 wils-311637
005 20235810432
008 230608t20042004NJU a #001 deng D
020 # # |a 9780470195109  |q hardcover 
020 # # |a 047019510X  |q hardcover 
040 # # |a DNLM  |d UiTM  |e rda 
041 0 # |a English 
060 0 0 |a QV 778 
090 0 0 |a QV778  |b N576d 2004 
100 1 # |a Ng, Rick  |e author 
245 1 0 |a Drugs  |b from discovery to approval  |c Rick Ng 
264 # 1 |a Hoboken, New Jersey  |b John Wiley & Sons, Hoboken  |c 2004 
264 # 4 |c ©2004 
300 # # |a xii, 355 pages  |b illustrations  |c 24 cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |b nc  |2 rdacarrier 
504 # # |a Includes bibliographical references and index 
520 # # |a The new edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products. Concise and easy to read, the book quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs. This second edition features many key enhancements, including Key Points, Chapter Summary, and Review Questions in each chapter, Answers to Review Questions provided in a book-end appendix, and one or two carefully selected "mini" case studies in each chapter. Richly illustrated throughout with over ninety figures and tables, this important book also includes helpful listings of current FDA and European guidelines and a special section on regulatory authority and processes in China. It is an indispensable resource for pharmaceutical industry and academic researchers, pharmaceutical managers and executives, healthcare clinicians, policymakers, regulators, and lobbyists with an interest in drug development. It is also an excellent textbook for students in pharmacy, science, and medicine courses 
650 1 2 |a Technology, Pharmaceutical 
650 2 2 |a Chemistry, Pharmaceutical 
650 2 2 |a Clinical Trials as Topic  |x methods 
650 2 2 |a Drug Approval  |x legislation & jurisprudence 
650 2 2 |a Drug Approval  |x methods 
650 2 2 |a Drug Design 
650 2 2 |a Drug Industry  |x methods 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=311637 
964 # # |c BOK  |d 01 
998 # # |a 00264#1a006.2.2||00264#1b006.2.2||00300##a006.2.2||00300##b006.2.2||00300##c006.2.2||00520##a006.2.2||00520##b006.2.2||